Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated to v3.6.4, indicating a newer version of the page's documentation. The core study content and details remain unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded Melanoma as a disease focus and included MedlinePlus Genetics under related topics. The update situates the study within the melanoma context and provides convenient access to genetics-related resources for users.SummaryDifference0.2%

- Check29 days agoChange DetectedThe related topics section was edited to drop the Melanoma topic and the MedlinePlus Genetics link. This reduces navigational cross-links to disease context and genetics resources on the page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, indicating a new revision of the page. This reflects behind-the-scenes updates to the study record or its accompanying documents.SummaryDifference0.1%

- Check44 days agoChange DetectedA new site revision, v3.6.2, replaces the previous v3.6.0, representing a minor update to the page's template/backend rather than content changes. This update does not affect the displayed study information, eligibility criteria, or enrollment details.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now indicates that recruitment is closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a minor heading formatting change for Intervention/Treatment and an updated revision label.SummaryDifference0.6%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.